nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP1A1—kidney cancer	0.143	0.653	CbGaD
Progesterone—ABCB1—kidney cancer	0.0759	0.347	CbGaD
Progesterone—CYP1B1—Erlotinib—kidney cancer	0.0221	0.0432	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0207	0.0404	CbGbCtD
Progesterone—CYP3A7—Temsirolimus—kidney cancer	0.0207	0.0404	CbGbCtD
Progesterone—ABCB11—Paclitaxel—kidney cancer	0.0202	0.0395	CbGbCtD
Progesterone—CYP1B1—Paclitaxel—kidney cancer	0.0202	0.0395	CbGbCtD
Progesterone—ABCC1—Dactinomycin—kidney cancer	0.0201	0.0393	CbGbCtD
Progesterone—SLC22A3—Vincristine—kidney cancer	0.019	0.0371	CbGbCtD
Progesterone—ABCB11—Vinblastine—kidney cancer	0.0177	0.0347	CbGbCtD
Progesterone—ABCB11—Vincristine—kidney cancer	0.0174	0.0341	CbGbCtD
Progesterone—CYP3A5—Temsirolimus—kidney cancer	0.0155	0.0303	CbGbCtD
Progesterone—ABCC1—Paclitaxel—kidney cancer	0.0144	0.0281	CbGbCtD
Progesterone—ABCC1—Vinblastine—kidney cancer	0.0126	0.0246	CbGbCtD
Progesterone—ABCC1—Vincristine—kidney cancer	0.0124	0.0242	CbGbCtD
Progesterone—SLC22A2—Vinblastine—kidney cancer	0.0114	0.0223	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—kidney cancer	0.0109	0.0213	CbGbCtD
Progesterone—ABCB11—Doxorubicin—kidney cancer	0.0109	0.0213	CbGbCtD
Progesterone—ABCB1—Temsirolimus—kidney cancer	0.0101	0.0197	CbGbCtD
Progesterone—CYP1A1—Erlotinib—kidney cancer	0.00969	0.0189	CbGbCtD
Progesterone—CYP2D6—Temsirolimus—kidney cancer	0.00952	0.0186	CbGbCtD
Progesterone—CYP3A4—Everolimus—kidney cancer	0.00896	0.0175	CbGbCtD
Progesterone—CYP2C8—Pazopanib—kidney cancer	0.00784	0.0153	CbGbCtD
Progesterone—ABCC1—Doxorubicin—kidney cancer	0.00774	0.0151	CbGbCtD
Progesterone—CYP3A7—Paclitaxel—kidney cancer	0.0071	0.0139	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0071	0.0139	CbGbCtD
Progesterone—NR3C2—collecting duct of renal tubule—kidney cancer	0.0065	0.128	CbGeAlD
Progesterone—CYP3A7—Sorafenib—kidney cancer	0.00631	0.0123	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00631	0.0123	CbGbCtD
Progesterone—CYP3A7—Vincristine—kidney cancer	0.00612	0.012	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00612	0.012	CbGbCtD
Progesterone—CYP1A2—Pazopanib—kidney cancer	0.00607	0.0119	CbGbCtD
Progesterone—CYP3A4—Temsirolimus—kidney cancer	0.00605	0.0118	CbGbCtD
Progesterone—CYP3A5—Erlotinib—kidney cancer	0.00582	0.0114	CbGbCtD
Progesterone—CYP2C9—Capecitabine—kidney cancer	0.0057	0.0111	CbGbCtD
Progesterone—CYP2C8—Erlotinib—kidney cancer	0.00559	0.0109	CbGbCtD
Progesterone—CYP3A5—Paclitaxel—kidney cancer	0.00533	0.0104	CbGbCtD
Progesterone—ABCB1—Pazopanib—kidney cancer	0.00531	0.0104	CbGbCtD
Progesterone—CYP2C8—Paclitaxel—kidney cancer	0.00512	0.01	CbGbCtD
Progesterone—CYP3A7—Sunitinib—kidney cancer	0.00511	0.00999	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00511	0.00999	CbGbCtD
Progesterone—CYP2D6—Pazopanib—kidney cancer	0.005	0.00977	CbGbCtD
Progesterone—ABCB1—Dactinomycin—kidney cancer	0.00485	0.00949	CbGbCtD
Progesterone—CYP3A5—Sorafenib—kidney cancer	0.00473	0.00925	CbGbCtD
Progesterone—CYP3A5—Vincristine—kidney cancer	0.00459	0.00898	CbGbCtD
Progesterone—CYP2C8—Sorafenib—kidney cancer	0.00455	0.00889	CbGbCtD
Progesterone—CYP1A2—Erlotinib—kidney cancer	0.00433	0.00846	CbGbCtD
Progesterone—ABCB1—Gemcitabine—kidney cancer	0.00384	0.0075	CbGbCtD
Progesterone—CYP3A5—Sunitinib—kidney cancer	0.00383	0.00749	CbGbCtD
Progesterone—CYP2C19—Sorafenib—kidney cancer	0.00382	0.00746	CbGbCtD
Progesterone—ABCB1—Erlotinib—kidney cancer	0.00379	0.0074	CbGbCtD
Progesterone—SLC22A2—nephron—kidney cancer	0.00364	0.0718	CbGeAlD
Progesterone—CYP2C9—Paclitaxel—kidney cancer	0.00357	0.00698	CbGbCtD
Progesterone—CYP2D6—Erlotinib—kidney cancer	0.00357	0.00697	CbGbCtD
Progesterone—CYP1A2—Sorafenib—kidney cancer	0.00352	0.00688	CbGbCtD
Progesterone—ABCB1—Paclitaxel—kidney cancer	0.00347	0.00677	CbGbCtD
Progesterone—CYP3A4—Pazopanib—kidney cancer	0.00318	0.00621	CbGbCtD
Progesterone—CYP2C9—Sorafenib—kidney cancer	0.00317	0.0062	CbGbCtD
Progesterone—ABCB1—Sorafenib—kidney cancer	0.00308	0.00602	CbGbCtD
Progesterone—ABCB1—Vinblastine—kidney cancer	0.00304	0.00594	CbGbCtD
Progesterone—ABCB1—Vincristine—kidney cancer	0.00299	0.00584	CbGbCtD
Progesterone—CYP2D6—Sorafenib—kidney cancer	0.0029	0.00567	CbGbCtD
Progesterone—NR3C2—nephron—kidney cancer	0.00289	0.0569	CbGeAlD
Progesterone—CYP2D6—Vinblastine—kidney cancer	0.00286	0.0056	CbGbCtD
Progesterone—ABCB1—Sunitinib—kidney cancer	0.00249	0.00488	CbGbCtD
Progesterone—CYP3A4—Erlotinib—kidney cancer	0.00227	0.00443	CbGbCtD
Progesterone—CYP3A4—Paclitaxel—kidney cancer	0.00208	0.00406	CbGbCtD
Progesterone—ABCB1—Doxorubicin—kidney cancer	0.00187	0.00365	CbGbCtD
Progesterone—CYP3A4—Sorafenib—kidney cancer	0.00184	0.00361	CbGbCtD
Progesterone—CYP3A4—Vinblastine—kidney cancer	0.00182	0.00356	CbGbCtD
Progesterone—CYP3A4—Vincristine—kidney cancer	0.00179	0.0035	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—kidney cancer	0.00176	0.00344	CbGbCtD
Progesterone—CYP2C19—urine—kidney cancer	0.00159	0.0313	CbGeAlD
Progesterone—CYP3A4—Sunitinib—kidney cancer	0.00149	0.00292	CbGbCtD
Progesterone—CYP1A2—urine—kidney cancer	0.0013	0.0256	CbGeAlD
Progesterone—NR3C1—urine—kidney cancer	0.00124	0.0245	CbGeAlD
Progesterone—CYP2C9—urine—kidney cancer	0.00123	0.0243	CbGeAlD
Progesterone—CYP3A4—Doxorubicin—kidney cancer	0.00112	0.00219	CbGbCtD
Progesterone—CYP3A4—urine—kidney cancer	0.000941	0.0185	CbGeAlD
Progesterone—CYP2D6—urine—kidney cancer	0.000926	0.0182	CbGeAlD
Progesterone—SLC10A1—renal system—kidney cancer	0.000901	0.0178	CbGeAlD
Progesterone—SLC10A1—kidney—kidney cancer	0.000871	0.0172	CbGeAlD
Progesterone—CYP17A1—nephron tubule—kidney cancer	0.000864	0.017	CbGeAlD
Progesterone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000815	0.0161	CbGeAlD
Progesterone—SLC10A1—gonad—kidney cancer	0.000808	0.0159	CbGeAlD
Progesterone—SLC22A2—nephron tubule—kidney cancer	0.000786	0.0155	CbGeAlD
Progesterone—CYP17A1—renal system—kidney cancer	0.000785	0.0155	CbGeAlD
Progesterone—CYP17A1—kidney—kidney cancer	0.000759	0.015	CbGeAlD
Progesterone—CYP17A1—cortex of kidney—kidney cancer	0.000739	0.0146	CbGeAlD
Progesterone—SLC22A2—renal system—kidney cancer	0.000715	0.0141	CbGeAlD
Progesterone—CYP17A1—gonad—kidney cancer	0.000704	0.0139	CbGeAlD
Progesterone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000698	0.0137	CbGeAlD
Progesterone—SLC22A2—kidney—kidney cancer	0.000691	0.0136	CbGeAlD
Progesterone—SLC22A2—cortex of kidney—kidney cancer	0.000673	0.0133	CbGeAlD
Progesterone—NR3C2—nephron tubule—kidney cancer	0.000624	0.0123	CbGeAlD
Progesterone—NR3C2—renal system—kidney cancer	0.000567	0.0112	CbGeAlD
Progesterone—NR3C2—kidney—kidney cancer	0.000548	0.0108	CbGeAlD
Progesterone—NR3C2—cortex of kidney—kidney cancer	0.000534	0.0105	CbGeAlD
Progesterone—SHBG—gonad—kidney cancer	0.000525	0.0103	CbGeAlD
Progesterone—SIGMAR1—nephron tubule—kidney cancer	0.000513	0.0101	CbGeAlD
Progesterone—NR3C2—cardiac atrium—kidney cancer	0.000508	0.01	CbGeAlD
Progesterone—SLC22A1—renal system—kidney cancer	0.000505	0.00995	CbGeAlD
Progesterone—SLC22A1—kidney—kidney cancer	0.000488	0.00962	CbGeAlD
Progesterone—CYP1B1—nephron tubule—kidney cancer	0.000488	0.00961	CbGeAlD
Progesterone—SLC22A3—renal system—kidney cancer	0.000483	0.00951	CbGeAlD
Progesterone—SLC22A3—kidney—kidney cancer	0.000467	0.00919	CbGeAlD
Progesterone—CYP1B1—renal system—kidney cancer	0.000444	0.00874	CbGeAlD
Progesterone—SIGMAR1—cortex of kidney—kidney cancer	0.000439	0.00865	CbGeAlD
Progesterone—SLC22A3—gonad—kidney cancer	0.000433	0.00853	CbGeAlD
Progesterone—CYP1B1—kidney—kidney cancer	0.000429	0.00845	CbGeAlD
Progesterone—AR—renal system—kidney cancer	0.00042	0.00828	CbGeAlD
Progesterone—SIGMAR1—cardiac atrium—kidney cancer	0.000418	0.00823	CbGeAlD
Progesterone—CYP1B1—cortex of kidney—kidney cancer	0.000418	0.00823	CbGeAlD
Progesterone—ESR1—renal system—kidney cancer	0.000412	0.00812	CbGeAlD
Progesterone—AR—kidney—kidney cancer	0.000406	0.008	CbGeAlD
Progesterone—Hydrocortisone—ANXA1—kidney cancer	0.000403	0.33	CrCbGaD
Progesterone—ESR1—kidney—kidney cancer	0.000399	0.00785	CbGeAlD
Progesterone—CYP1B1—gonad—kidney cancer	0.000398	0.00784	CbGeAlD
Progesterone—AR—cortex of kidney—kidney cancer	0.000396	0.00779	CbGeAlD
Progesterone—AR—gonad—kidney cancer	0.000377	0.00742	CbGeAlD
Progesterone—AR—cardiac atrium—kidney cancer	0.000376	0.00741	CbGeAlD
Progesterone—ABCC1—cortex of kidney—kidney cancer	0.000376	0.0074	CbGeAlD
Progesterone—ESR1—gonad—kidney cancer	0.00037	0.00729	CbGeAlD
Progesterone—ABCC1—cardiac atrium—kidney cancer	0.000357	0.00704	CbGeAlD
Progesterone—CYP2C8—renal system—kidney cancer	0.00034	0.00669	CbGeAlD
Progesterone—CYP3A5—nephron tubule—kidney cancer	0.000337	0.00664	CbGeAlD
Progesterone—NR3C1—nephron tubule—kidney cancer	0.000335	0.00659	CbGeAlD
Progesterone—CYP2C8—kidney—kidney cancer	0.000328	0.00647	CbGeAlD
Progesterone—CYP1A2—renal system—kidney cancer	0.000318	0.00626	CbGeAlD
Progesterone—CYP1A1—renal system—kidney cancer	0.000314	0.00618	CbGeAlD
Progesterone—CYP3A5—renal system—kidney cancer	0.000307	0.00604	CbGeAlD
Progesterone—NR3C1—renal system—kidney cancer	0.000304	0.00599	CbGeAlD
Progesterone—CYP1A1—kidney—kidney cancer	0.000303	0.00597	CbGeAlD
Progesterone—CYP3A5—kidney—kidney cancer	0.000296	0.00584	CbGeAlD
Progesterone—NR3C1—kidney—kidney cancer	0.000294	0.00579	CbGeAlD
Progesterone—CYP3A5—cortex of kidney—kidney cancer	0.000289	0.00569	CbGeAlD
Progesterone—NR3C1—cortex of kidney—kidney cancer	0.000287	0.00564	CbGeAlD
Progesterone—CYP1A1—cardiac atrium—kidney cancer	0.000281	0.00553	CbGeAlD
Progesterone—NR3C1—gonad—kidney cancer	0.000273	0.00537	CbGeAlD
Progesterone—NR3C1—cardiac atrium—kidney cancer	0.000273	0.00537	CbGeAlD
Progesterone—Drospirenone—BCHE—kidney cancer	0.000248	0.204	CrCbGaD
Progesterone—CYP3A4—renal system—kidney cancer	0.00023	0.00453	CbGeAlD
Progesterone—CYP2D6—renal system—kidney cancer	0.000226	0.00446	CbGeAlD
Progesterone—CYP3A4—kidney—kidney cancer	0.000222	0.00438	CbGeAlD
Progesterone—CYP2D6—kidney—kidney cancer	0.000219	0.00431	CbGeAlD
Progesterone—ABCB1—nephron tubule—kidney cancer	0.000179	0.00353	CbGeAlD
Progesterone—ABCB1—renal system—kidney cancer	0.000163	0.00321	CbGeAlD
Progesterone—ABCB1—kidney—kidney cancer	0.000157	0.0031	CbGeAlD
Progesterone—ABCB1—cortex of kidney—kidney cancer	0.000153	0.00302	CbGeAlD
Progesterone—ABCB1—gonad—kidney cancer	0.000146	0.00288	CbGeAlD
Progesterone—Drospirenone—PTGS2—kidney cancer	0.000114	0.0939	CrCbGaD
Progesterone—Megestrol acetate—ABCB1—kidney cancer	0.000111	0.0914	CrCbGaD
Progesterone—Spironolactone—ABCB1—kidney cancer	6.92e-05	0.0568	CrCbGaD
Progesterone—Testosterone—CYP1A1—kidney cancer	6.67e-05	0.0547	CrCbGaD
Progesterone—Norethindrone—ABCB1—kidney cancer	6.43e-05	0.0528	CrCbGaD
Progesterone—Prednisolone—ABCB1—kidney cancer	6.01e-05	0.0494	CrCbGaD
Progesterone—Gastrointestinal pain—Vincristine—kidney cancer	5.18e-05	0.000342	CcSEcCtD
Progesterone—Dizziness—Sorafenib—kidney cancer	5.15e-05	0.00034	CcSEcCtD
Progesterone—Pain—Gemcitabine—kidney cancer	5.14e-05	0.000339	CcSEcCtD
Progesterone—Constipation—Gemcitabine—kidney cancer	5.14e-05	0.000339	CcSEcCtD
Progesterone—Nausea—Erlotinib—kidney cancer	5.14e-05	0.000339	CcSEcCtD
Progesterone—Alopecia—Capecitabine—kidney cancer	5.14e-05	0.000339	CcSEcCtD
Progesterone—Dry mouth—Paclitaxel—kidney cancer	5.14e-05	0.000339	CcSEcCtD
Progesterone—Mood swings—Doxorubicin—kidney cancer	5.13e-05	0.000339	CcSEcCtD
Progesterone—Diarrhoea—Sunitinib—kidney cancer	5.13e-05	0.000338	CcSEcCtD
Progesterone—Mental disorder—Capecitabine—kidney cancer	5.1e-05	0.000336	CcSEcCtD
Progesterone—Asthenia—Dactinomycin—kidney cancer	5.09e-05	0.000336	CcSEcCtD
Progesterone—Confusional state—Paclitaxel—kidney cancer	5.08e-05	0.000335	CcSEcCtD
Progesterone—Malnutrition—Capecitabine—kidney cancer	5.06e-05	0.000334	CcSEcCtD
Progesterone—Erythema—Capecitabine—kidney cancer	5.06e-05	0.000334	CcSEcCtD
Progesterone—Oedema—Paclitaxel—kidney cancer	5.04e-05	0.000332	CcSEcCtD
Progesterone—Anaphylactic shock—Paclitaxel—kidney cancer	5.04e-05	0.000332	CcSEcCtD
Progesterone—Abdominal pain—Vincristine—kidney cancer	5.01e-05	0.000331	CcSEcCtD
Progesterone—Body temperature increased—Vincristine—kidney cancer	5.01e-05	0.000331	CcSEcCtD
Progesterone—Liver function test abnormal—Doxorubicin—kidney cancer	5e-05	0.00033	CcSEcCtD
Progesterone—Infection—Paclitaxel—kidney cancer	5e-05	0.00033	CcSEcCtD
Progesterone—Flatulence—Capecitabine—kidney cancer	4.99e-05	0.000329	CcSEcCtD
Progesterone—Dizziness—Sunitinib—kidney cancer	4.96e-05	0.000327	CcSEcCtD
Progesterone—Feeling abnormal—Gemcitabine—kidney cancer	4.96e-05	0.000327	CcSEcCtD
Progesterone—Shock—Paclitaxel—kidney cancer	4.95e-05	0.000327	CcSEcCtD
Progesterone—Vomiting—Sorafenib—kidney cancer	4.95e-05	0.000327	CcSEcCtD
Progesterone—Nervous system disorder—Paclitaxel—kidney cancer	4.94e-05	0.000326	CcSEcCtD
Progesterone—Tachycardia—Paclitaxel—kidney cancer	4.91e-05	0.000324	CcSEcCtD
Progesterone—Rash—Sorafenib—kidney cancer	4.91e-05	0.000324	CcSEcCtD
Progesterone—Dermatitis—Sorafenib—kidney cancer	4.91e-05	0.000324	CcSEcCtD
Progesterone—Back pain—Capecitabine—kidney cancer	4.9e-05	0.000323	CcSEcCtD
Progesterone—Breast disorder—Doxorubicin—kidney cancer	4.9e-05	0.000323	CcSEcCtD
Progesterone—Skin disorder—Paclitaxel—kidney cancer	4.89e-05	0.000323	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.88e-05	0.000322	CcSEcCtD
Progesterone—Headache—Sorafenib—kidney cancer	4.88e-05	0.000322	CcSEcCtD
Progesterone—Muscle spasms—Capecitabine—kidney cancer	4.87e-05	0.000321	CcSEcCtD
Progesterone—Hyperhidrosis—Paclitaxel—kidney cancer	4.87e-05	0.000321	CcSEcCtD
Progesterone—Diarrhoea—Dactinomycin—kidney cancer	4.85e-05	0.00032	CcSEcCtD
Progesterone—Nasopharyngitis—Doxorubicin—kidney cancer	4.85e-05	0.00032	CcSEcCtD
Progesterone—Anorexia—Paclitaxel—kidney cancer	4.8e-05	0.000317	CcSEcCtD
Progesterone—Gastritis—Doxorubicin—kidney cancer	4.8e-05	0.000316	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.78e-05	0.000315	CcSEcCtD
Progesterone—Vision blurred—Capecitabine—kidney cancer	4.77e-05	0.000315	CcSEcCtD
Progesterone—Vomiting—Sunitinib—kidney cancer	4.77e-05	0.000314	CcSEcCtD
Progesterone—Body temperature increased—Gemcitabine—kidney cancer	4.75e-05	0.000314	CcSEcCtD
Progesterone—Tremor—Capecitabine—kidney cancer	4.74e-05	0.000313	CcSEcCtD
Progesterone—Rash—Sunitinib—kidney cancer	4.73e-05	0.000312	CcSEcCtD
Progesterone—Dermatitis—Sunitinib—kidney cancer	4.72e-05	0.000311	CcSEcCtD
Progesterone—Abdominal distension—Doxorubicin—kidney cancer	4.72e-05	0.000311	CcSEcCtD
Progesterone—Hypotension—Paclitaxel—kidney cancer	4.7e-05	0.00031	CcSEcCtD
Progesterone—Ill-defined disorder—Capecitabine—kidney cancer	4.7e-05	0.00031	CcSEcCtD
Progesterone—Headache—Sunitinib—kidney cancer	4.7e-05	0.00031	CcSEcCtD
Progesterone—Asthma—Doxorubicin—kidney cancer	4.68e-05	0.000309	CcSEcCtD
Progesterone—Dysphagia—Doxorubicin—kidney cancer	4.68e-05	0.000309	CcSEcCtD
Progesterone—Anaemia—Capecitabine—kidney cancer	4.68e-05	0.000309	CcSEcCtD
Progesterone—Hypersensitivity—Vincristine—kidney cancer	4.67e-05	0.000308	CcSEcCtD
Progesterone—Nausea—Sorafenib—kidney cancer	4.63e-05	0.000305	CcSEcCtD
Progesterone—Hydrocortisone—ABCB1—kidney cancer	4.6e-05	0.0377	CrCbGaD
Progesterone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.59e-05	0.000303	CcSEcCtD
Progesterone—Malaise—Capecitabine—kidney cancer	4.57e-05	0.000301	CcSEcCtD
Progesterone—Angina pectoris—Doxorubicin—kidney cancer	4.56e-05	0.000301	CcSEcCtD
Progesterone—Insomnia—Paclitaxel—kidney cancer	4.55e-05	0.0003	CcSEcCtD
Progesterone—Vertigo—Capecitabine—kidney cancer	4.55e-05	0.0003	CcSEcCtD
Progesterone—Asthenia—Vincristine—kidney cancer	4.55e-05	0.0003	CcSEcCtD
Progesterone—Syncope—Capecitabine—kidney cancer	4.54e-05	0.000299	CcSEcCtD
Progesterone—Paraesthesia—Paclitaxel—kidney cancer	4.52e-05	0.000298	CcSEcCtD
Progesterone—Vomiting—Dactinomycin—kidney cancer	4.51e-05	0.000298	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—kidney cancer	4.5e-05	0.000297	CcSEcCtD
Progesterone—Dyspnoea—Paclitaxel—kidney cancer	4.49e-05	0.000296	CcSEcCtD
Progesterone—Somnolence—Paclitaxel—kidney cancer	4.48e-05	0.000295	CcSEcCtD
Progesterone—Palpitations—Capecitabine—kidney cancer	4.47e-05	0.000295	CcSEcCtD
Progesterone—Rash—Dactinomycin—kidney cancer	4.47e-05	0.000295	CcSEcCtD
Progesterone—Nausea—Sunitinib—kidney cancer	4.45e-05	0.000294	CcSEcCtD
Progesterone—Loss of consciousness—Capecitabine—kidney cancer	4.45e-05	0.000293	CcSEcCtD
Progesterone—Dyspepsia—Paclitaxel—kidney cancer	4.43e-05	0.000292	CcSEcCtD
Progesterone—Cough—Capecitabine—kidney cancer	4.42e-05	0.000291	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—kidney cancer	4.38e-05	0.000289	CcSEcCtD
Progesterone—Decreased appetite—Paclitaxel—kidney cancer	4.38e-05	0.000289	CcSEcCtD
Progesterone—Hypertension—Capecitabine—kidney cancer	4.37e-05	0.000288	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—kidney cancer	4.35e-05	0.000287	CcSEcCtD
Progesterone—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.35e-05	0.000287	CcSEcCtD
Progesterone—Fatigue—Paclitaxel—kidney cancer	4.34e-05	0.000286	CcSEcCtD
Progesterone—Diarrhoea—Vincristine—kidney cancer	4.34e-05	0.000286	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—kidney cancer	4.33e-05	0.000285	CcSEcCtD
Progesterone—Asthenia—Gemcitabine—kidney cancer	4.31e-05	0.000285	CcSEcCtD
Progesterone—Arthralgia—Capecitabine—kidney cancer	4.31e-05	0.000284	CcSEcCtD
Progesterone—Chest pain—Capecitabine—kidney cancer	4.31e-05	0.000284	CcSEcCtD
Progesterone—Myalgia—Capecitabine—kidney cancer	4.31e-05	0.000284	CcSEcCtD
Progesterone—Pain—Paclitaxel—kidney cancer	4.31e-05	0.000284	CcSEcCtD
Progesterone—Constipation—Paclitaxel—kidney cancer	4.31e-05	0.000284	CcSEcCtD
Progesterone—Anxiety—Capecitabine—kidney cancer	4.3e-05	0.000283	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.28e-05	0.000282	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—kidney cancer	4.26e-05	0.000281	CcSEcCtD
Progesterone—Discomfort—Capecitabine—kidney cancer	4.26e-05	0.000281	CcSEcCtD
Progesterone—Pruritus—Gemcitabine—kidney cancer	4.25e-05	0.000281	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—kidney cancer	4.24e-05	0.000279	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—kidney cancer	4.23e-05	0.000279	CcSEcCtD
Progesterone—Dry mouth—Capecitabine—kidney cancer	4.22e-05	0.000278	CcSEcCtD
Progesterone—Nausea—Dactinomycin—kidney cancer	4.21e-05	0.000278	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—kidney cancer	4.2e-05	0.000277	CcSEcCtD
Progesterone—Dizziness—Vincristine—kidney cancer	4.19e-05	0.000276	CcSEcCtD
Progesterone—Infestation—Doxorubicin—kidney cancer	4.18e-05	0.000275	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—kidney cancer	4.18e-05	0.000275	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—kidney cancer	4.18e-05	0.000275	CcSEcCtD
Progesterone—Confusional state—Capecitabine—kidney cancer	4.17e-05	0.000275	CcSEcCtD
Progesterone—Feeling abnormal—Paclitaxel—kidney cancer	4.15e-05	0.000274	CcSEcCtD
Progesterone—Oedema—Capecitabine—kidney cancer	4.13e-05	0.000273	CcSEcCtD
Progesterone—Gastrointestinal pain—Paclitaxel—kidney cancer	4.12e-05	0.000272	CcSEcCtD
Progesterone—Diarrhoea—Gemcitabine—kidney cancer	4.11e-05	0.000271	CcSEcCtD
Progesterone—Infection—Capecitabine—kidney cancer	4.11e-05	0.000271	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—kidney cancer	4.09e-05	0.00027	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—kidney cancer	4.07e-05	0.000268	CcSEcCtD
Progesterone—Shock—Capecitabine—kidney cancer	4.07e-05	0.000268	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—kidney cancer	4.06e-05	0.000268	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—kidney cancer	4.06e-05	0.000268	CcSEcCtD
Progesterone—Nervous system disorder—Capecitabine—kidney cancer	4.05e-05	0.000267	CcSEcCtD
Progesterone—Tachycardia—Capecitabine—kidney cancer	4.03e-05	0.000266	CcSEcCtD
Progesterone—Vomiting—Vincristine—kidney cancer	4.03e-05	0.000266	CcSEcCtD
Progesterone—Skin disorder—Capecitabine—kidney cancer	4.01e-05	0.000265	CcSEcCtD
Progesterone—Urticaria—Paclitaxel—kidney cancer	4e-05	0.000264	CcSEcCtD
Progesterone—Rash—Vincristine—kidney cancer	4e-05	0.000264	CcSEcCtD
Progesterone—Hyperhidrosis—Capecitabine—kidney cancer	3.99e-05	0.000263	CcSEcCtD
Progesterone—Dermatitis—Vincristine—kidney cancer	3.99e-05	0.000263	CcSEcCtD
Progesterone—Abdominal pain—Paclitaxel—kidney cancer	3.98e-05	0.000263	CcSEcCtD
Progesterone—Body temperature increased—Paclitaxel—kidney cancer	3.98e-05	0.000263	CcSEcCtD
Progesterone—Headache—Vincristine—kidney cancer	3.97e-05	0.000262	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—kidney cancer	3.95e-05	0.00026	CcSEcCtD
Progesterone—Anorexia—Capecitabine—kidney cancer	3.94e-05	0.00026	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—kidney cancer	3.92e-05	0.000258	CcSEcCtD
Progesterone—Hypotension—Capecitabine—kidney cancer	3.86e-05	0.000255	CcSEcCtD
Progesterone—Vomiting—Gemcitabine—kidney cancer	3.82e-05	0.000252	CcSEcCtD
Progesterone—Rash—Gemcitabine—kidney cancer	3.79e-05	0.00025	CcSEcCtD
Progesterone—Dermatitis—Gemcitabine—kidney cancer	3.79e-05	0.00025	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—kidney cancer	3.77e-05	0.000249	CcSEcCtD
Progesterone—Headache—Gemcitabine—kidney cancer	3.77e-05	0.000248	CcSEcCtD
Progesterone—Nausea—Vincristine—kidney cancer	3.77e-05	0.000248	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.76e-05	0.000248	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—kidney cancer	3.76e-05	0.000248	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—kidney cancer	3.75e-05	0.000247	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—kidney cancer	3.75e-05	0.000247	CcSEcCtD
Progesterone—Insomnia—Capecitabine—kidney cancer	3.74e-05	0.000246	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—kidney cancer	3.72e-05	0.000245	CcSEcCtD
Progesterone—Paraesthesia—Capecitabine—kidney cancer	3.71e-05	0.000245	CcSEcCtD
Progesterone—Hypersensitivity—Paclitaxel—kidney cancer	3.71e-05	0.000245	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—kidney cancer	3.7e-05	0.000244	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—kidney cancer	3.69e-05	0.000244	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—kidney cancer	3.68e-05	0.000243	CcSEcCtD
Progesterone—Dyspnoea—Capecitabine—kidney cancer	3.68e-05	0.000243	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—kidney cancer	3.67e-05	0.000242	CcSEcCtD
Progesterone—Dyspepsia—Capecitabine—kidney cancer	3.64e-05	0.00024	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—kidney cancer	3.61e-05	0.000238	CcSEcCtD
Progesterone—Asthenia—Paclitaxel—kidney cancer	3.61e-05	0.000238	CcSEcCtD
Progesterone—Decreased appetite—Capecitabine—kidney cancer	3.59e-05	0.000237	CcSEcCtD
Progesterone—Nausea—Gemcitabine—kidney cancer	3.57e-05	0.000236	CcSEcCtD
Progesterone—Gastrointestinal disorder—Capecitabine—kidney cancer	3.57e-05	0.000235	CcSEcCtD
Progesterone—Fatigue—Capecitabine—kidney cancer	3.56e-05	0.000235	CcSEcCtD
Progesterone—Pruritus—Paclitaxel—kidney cancer	3.56e-05	0.000235	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—kidney cancer	3.54e-05	0.000234	CcSEcCtD
Progesterone—Testosterone—ABCB1—kidney cancer	3.54e-05	0.0291	CrCbGaD
Progesterone—Pain—Capecitabine—kidney cancer	3.53e-05	0.000233	CcSEcCtD
Progesterone—Constipation—Capecitabine—kidney cancer	3.53e-05	0.000233	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—kidney cancer	3.5e-05	0.000231	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—kidney cancer	3.5e-05	0.000231	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—kidney cancer	3.48e-05	0.000229	CcSEcCtD
Progesterone—Diarrhoea—Paclitaxel—kidney cancer	3.45e-05	0.000227	CcSEcCtD
Progesterone—Feeling abnormal—Capecitabine—kidney cancer	3.41e-05	0.000225	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—kidney cancer	3.4e-05	0.000224	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—kidney cancer	3.39e-05	0.000223	CcSEcCtD
Progesterone—Gastrointestinal pain—Capecitabine—kidney cancer	3.38e-05	0.000223	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—kidney cancer	3.38e-05	0.000223	CcSEcCtD
Progesterone—Dizziness—Paclitaxel—kidney cancer	3.33e-05	0.00022	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—kidney cancer	3.31e-05	0.000218	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—kidney cancer	3.28e-05	0.000217	CcSEcCtD
Progesterone—Urticaria—Capecitabine—kidney cancer	3.28e-05	0.000216	CcSEcCtD
Progesterone—Abdominal pain—Capecitabine—kidney cancer	3.27e-05	0.000215	CcSEcCtD
Progesterone—Body temperature increased—Capecitabine—kidney cancer	3.27e-05	0.000215	CcSEcCtD
Progesterone—Erythema—Doxorubicin—kidney cancer	3.26e-05	0.000215	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—kidney cancer	3.26e-05	0.000215	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—kidney cancer	3.22e-05	0.000212	CcSEcCtD
Progesterone—Tension—Doxorubicin—kidney cancer	3.2e-05	0.000211	CcSEcCtD
Progesterone—Vomiting—Paclitaxel—kidney cancer	3.2e-05	0.000211	CcSEcCtD
Progesterone—Rash—Paclitaxel—kidney cancer	3.17e-05	0.000209	CcSEcCtD
Progesterone—Dermatitis—Paclitaxel—kidney cancer	3.17e-05	0.000209	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—kidney cancer	3.17e-05	0.000209	CcSEcCtD
Progesterone—Back pain—Doxorubicin—kidney cancer	3.16e-05	0.000208	CcSEcCtD
Progesterone—Headache—Paclitaxel—kidney cancer	3.15e-05	0.000208	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—kidney cancer	3.14e-05	0.000207	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—kidney cancer	3.08e-05	0.000203	CcSEcCtD
Progesterone—Hypersensitivity—Capecitabine—kidney cancer	3.04e-05	0.000201	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—kidney cancer	3.03e-05	0.0002	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—kidney cancer	3.02e-05	0.000199	CcSEcCtD
Progesterone—Nausea—Paclitaxel—kidney cancer	2.99e-05	0.000197	CcSEcCtD
Progesterone—Asthenia—Capecitabine—kidney cancer	2.96e-05	0.000196	CcSEcCtD
Progesterone—Malaise—Doxorubicin—kidney cancer	2.94e-05	0.000194	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—kidney cancer	2.93e-05	0.000193	CcSEcCtD
Progesterone—Syncope—Doxorubicin—kidney cancer	2.93e-05	0.000193	CcSEcCtD
Progesterone—Pruritus—Capecitabine—kidney cancer	2.92e-05	0.000193	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—kidney cancer	2.88e-05	0.00019	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—kidney cancer	2.87e-05	0.000189	CcSEcCtD
Progesterone—Cough—Doxorubicin—kidney cancer	2.85e-05	0.000188	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—kidney cancer	2.83e-05	0.000186	CcSEcCtD
Progesterone—Diarrhoea—Capecitabine—kidney cancer	2.83e-05	0.000186	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—kidney cancer	2.82e-05	0.000186	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—kidney cancer	2.78e-05	0.000183	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—kidney cancer	2.78e-05	0.000183	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—kidney cancer	2.78e-05	0.000183	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—kidney cancer	2.77e-05	0.000183	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.76e-05	0.000182	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—kidney cancer	2.75e-05	0.000181	CcSEcCtD
Progesterone—Dizziness—Capecitabine—kidney cancer	2.73e-05	0.00018	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—kidney cancer	2.72e-05	0.000179	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—kidney cancer	2.69e-05	0.000177	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—kidney cancer	2.66e-05	0.000176	CcSEcCtD
Progesterone—Oedema—Doxorubicin—kidney cancer	2.66e-05	0.000176	CcSEcCtD
Progesterone—Infection—Doxorubicin—kidney cancer	2.65e-05	0.000175	CcSEcCtD
Progesterone—Vomiting—Capecitabine—kidney cancer	2.63e-05	0.000173	CcSEcCtD
Progesterone—Shock—Doxorubicin—kidney cancer	2.62e-05	0.000173	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—kidney cancer	2.61e-05	0.000172	CcSEcCtD
Progesterone—Rash—Capecitabine—kidney cancer	2.61e-05	0.000172	CcSEcCtD
Progesterone—Dermatitis—Capecitabine—kidney cancer	2.6e-05	0.000172	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—kidney cancer	2.6e-05	0.000171	CcSEcCtD
Progesterone—Headache—Capecitabine—kidney cancer	2.59e-05	0.000171	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—kidney cancer	2.59e-05	0.000171	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—kidney cancer	2.57e-05	0.00017	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—kidney cancer	2.54e-05	0.000167	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—kidney cancer	2.49e-05	0.000164	CcSEcCtD
Progesterone—Nausea—Capecitabine—kidney cancer	2.45e-05	0.000162	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.43e-05	0.00016	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—kidney cancer	2.41e-05	0.000159	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—kidney cancer	2.39e-05	0.000158	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—kidney cancer	2.37e-05	0.000157	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—kidney cancer	2.37e-05	0.000156	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—kidney cancer	2.34e-05	0.000155	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—kidney cancer	2.32e-05	0.000153	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.3e-05	0.000152	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—kidney cancer	2.3e-05	0.000151	CcSEcCtD
Progesterone—Pain—Doxorubicin—kidney cancer	2.28e-05	0.00015	CcSEcCtD
Progesterone—Constipation—Doxorubicin—kidney cancer	2.28e-05	0.00015	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—kidney cancer	2.19e-05	0.000145	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—kidney cancer	2.18e-05	0.000144	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—kidney cancer	2.12e-05	0.00014	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—kidney cancer	2.11e-05	0.000139	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—kidney cancer	2.11e-05	0.000139	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—kidney cancer	1.96e-05	0.000129	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—kidney cancer	1.91e-05	0.000126	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—kidney cancer	1.88e-05	0.000124	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—kidney cancer	1.82e-05	0.00012	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—kidney cancer	1.76e-05	0.000116	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—kidney cancer	1.69e-05	0.000112	CcSEcCtD
Progesterone—Rash—Doxorubicin—kidney cancer	1.68e-05	0.000111	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—kidney cancer	1.68e-05	0.000111	CcSEcCtD
Progesterone—Headache—Doxorubicin—kidney cancer	1.67e-05	0.00011	CcSEcCtD
Progesterone—Nausea—Doxorubicin—kidney cancer	1.58e-05	0.000104	CcSEcCtD
Progesterone—PGR—Signaling Pathways—ERBB2—kidney cancer	4.07e-06	6.15e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—SLC5A5—kidney cancer	4.06e-06	6.15e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—LDHB—kidney cancer	4.05e-06	6.13e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MTOR—kidney cancer	4.01e-06	6.07e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—SCARB1—kidney cancer	3.99e-06	6.03e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS1—kidney cancer	3.95e-06	5.97e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	3.93e-06	5.94e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.92e-06	5.94e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—POMC—kidney cancer	3.9e-06	5.91e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SCARB1—kidney cancer	3.89e-06	5.89e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—POMC—kidney cancer	3.89e-06	5.89e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.88e-06	5.88e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTT1—kidney cancer	3.87e-06	5.86e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ACHE—kidney cancer	3.87e-06	5.86e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CRABP1—kidney cancer	3.87e-06	5.86e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PSMD7—kidney cancer	3.87e-06	5.86e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—BRAF—kidney cancer	3.85e-06	5.83e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS1—kidney cancer	3.85e-06	5.83e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ACHE—kidney cancer	3.84e-06	5.81e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTT1—kidney cancer	3.84e-06	5.81e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—RAF1—kidney cancer	3.83e-06	5.8e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.81e-06	5.76e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—ERBB2—kidney cancer	3.79e-06	5.73e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PSMD7—kidney cancer	3.78e-06	5.72e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTP1—kidney cancer	3.78e-06	5.72e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CDKN1B—kidney cancer	3.77e-06	5.7e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—POMC—kidney cancer	3.76e-06	5.69e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTEN—kidney cancer	3.76e-06	5.69e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MTOR—kidney cancer	3.74e-06	5.66e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	3.74e-06	5.66e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CD4—kidney cancer	3.73e-06	5.65e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—kidney cancer	3.71e-06	5.61e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL2—kidney cancer	3.68e-06	5.58e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—BCHE—kidney cancer	3.67e-06	5.55e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SCARB1—kidney cancer	3.67e-06	5.55e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SCARB1—kidney cancer	3.64e-06	5.5e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS1—kidney cancer	3.63e-06	5.49e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.62e-06	5.49e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.62e-06	5.48e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTEN—kidney cancer	3.6e-06	5.45e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ITPR2—kidney cancer	3.6e-06	5.45e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS1—kidney cancer	3.6e-06	5.45e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCND1—kidney cancer	3.59e-06	5.44e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—JUN—kidney cancer	3.58e-06	5.42e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—BCHE—kidney cancer	3.58e-06	5.42e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ABCB1—kidney cancer	3.57e-06	5.41e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	3.57e-06	5.4e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTP1—kidney cancer	3.57e-06	5.4e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PSMD7—kidney cancer	3.56e-06	5.39e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CTNNB1—kidney cancer	3.56e-06	5.38e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SLC5A5—kidney cancer	3.54e-06	5.35e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—KRAS—kidney cancer	3.53e-06	5.34e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PSMD7—kidney cancer	3.53e-06	5.34e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CA9—kidney cancer	3.51e-06	5.32e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CDKN1B—kidney cancer	3.51e-06	5.31e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.5e-06	5.3e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HIF1A—kidney cancer	3.49e-06	5.28e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TSC2—kidney cancer	3.48e-06	5.27e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—MAPK3—kidney cancer	3.47e-06	5.25e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTM1—kidney cancer	3.47e-06	5.25e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTEN—kidney cancer	3.47e-06	5.25e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SLC2A1—kidney cancer	3.42e-06	5.17e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.4e-06	5.14e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—POMC—kidney cancer	3.39e-06	5.14e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—POMC—kidney cancer	3.39e-06	5.13e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ABCB1—kidney cancer	3.38e-06	5.11e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—MYC—kidney cancer	3.38e-06	5.11e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—BCHE—kidney cancer	3.38e-06	5.11e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—BCHE—kidney cancer	3.35e-06	5.06e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KDR—kidney cancer	3.34e-06	5.05e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.33e-06	5.05e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.32e-06	5.02e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.32e-06	5.02e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—kidney cancer	3.32e-06	5.02e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.3e-06	5e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.29e-06	4.98e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ACHE—kidney cancer	3.28e-06	4.97e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTT1—kidney cancer	3.28e-06	4.97e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTM1—kidney cancer	3.28e-06	4.96e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTP1—kidney cancer	3.27e-06	4.95e-05	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.26e-06	4.93e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	3.24e-06	4.91e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTEN—kidney cancer	3.23e-06	4.89e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.22e-06	4.87e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RAF1—kidney cancer	3.22e-06	4.87e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RELA—kidney cancer	3.2e-06	4.85e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.19e-06	4.83e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB2—kidney cancer	3.18e-06	4.82e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—kidney cancer	3.17e-06	4.79e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—POMC—kidney cancer	3.16e-06	4.78e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MTOR—kidney cancer	3.14e-06	4.76e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—kidney cancer	3.13e-06	4.74e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—POMC—kidney cancer	3.11e-06	4.71e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SCARB1—kidney cancer	3.11e-06	4.7e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—kidney cancer	3.1e-06	4.7e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.1e-06	4.69e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ABCB1—kidney cancer	3.1e-06	4.69e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS1—kidney cancer	3.08e-06	4.65e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KIT—kidney cancer	3.07e-06	4.65e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APC—kidney cancer	3.07e-06	4.65e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PSMD7—kidney cancer	3.02e-06	4.56e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTM1—kidney cancer	3.01e-06	4.55e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—kidney cancer	3e-06	4.54e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CRABP1—kidney cancer	2.99e-06	4.52e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK3—kidney cancer	2.96e-06	4.48e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.96e-06	4.48e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	2.95e-06	4.46e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—POMC—kidney cancer	2.93e-06	4.43e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTP1—kidney cancer	2.92e-06	4.42e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—kidney cancer	2.89e-06	4.37e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—kidney cancer	2.89e-06	4.37e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—kidney cancer	2.88e-06	4.36e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—BCHE—kidney cancer	2.86e-06	4.33e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTP1—kidney cancer	2.85e-06	4.31e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.85e-06	4.31e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.82e-06	4.27e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK1—kidney cancer	2.82e-06	4.27e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—kidney cancer	2.81e-06	4.26e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—JUN—kidney cancer	2.81e-06	4.25e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	2.79e-06	4.22e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ITPR2—kidney cancer	2.78e-06	4.2e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ABCB1—kidney cancer	2.76e-06	4.18e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK3—kidney cancer	2.76e-06	4.18e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.73e-06	4.13e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—kidney cancer	2.72e-06	4.11e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—kidney cancer	2.71e-06	4.1e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—kidney cancer	2.71e-06	4.1e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—kidney cancer	2.7e-06	4.09e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.7e-06	4.09e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—kidney cancer	2.69e-06	4.06e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTP1—kidney cancer	2.69e-06	4.06e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTM1—kidney cancer	2.68e-06	4.06e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MAPK3—kidney cancer	2.67e-06	4.05e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—kidney cancer	2.66e-06	4.03e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTP1—kidney cancer	2.66e-06	4.03e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—kidney cancer	2.65e-06	4.01e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.65e-06	4e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MAPK3—kidney cancer	2.63e-06	3.99e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK1—kidney cancer	2.63e-06	3.98e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTM1—kidney cancer	2.62e-06	3.96e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—kidney cancer	2.62e-06	3.96e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—kidney cancer	2.6e-06	3.94e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—kidney cancer	2.56e-06	3.88e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.55e-06	3.86e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.54e-06	3.85e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ABCB1—kidney cancer	2.54e-06	3.85e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—kidney cancer	2.54e-06	3.85e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTT1—kidney cancer	2.53e-06	3.83e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ACHE—kidney cancer	2.53e-06	3.83e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ABCB1—kidney cancer	2.52e-06	3.81e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—kidney cancer	2.52e-06	3.81e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1A1—kidney cancer	2.48e-06	3.76e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—kidney cancer	2.48e-06	3.76e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—kidney cancer	2.48e-06	3.75e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTM1—kidney cancer	2.47e-06	3.73e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—POMC—kidney cancer	2.45e-06	3.71e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—kidney cancer	2.45e-06	3.71e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTM1—kidney cancer	2.45e-06	3.7e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—kidney cancer	2.45e-06	3.7e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RAF1—kidney cancer	2.41e-06	3.65e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RELA—kidney cancer	2.4e-06	3.63e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SCARB1—kidney cancer	2.4e-06	3.63e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—kidney cancer	2.39e-06	3.61e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS1—kidney cancer	2.37e-06	3.59e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—kidney cancer	2.37e-06	3.58e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—kidney cancer	2.36e-06	3.57e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—kidney cancer	2.36e-06	3.57e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MTOR—kidney cancer	2.35e-06	3.56e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.34e-06	3.54e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.34e-06	3.54e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PSMD7—kidney cancer	2.33e-06	3.52e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK3—kidney cancer	2.32e-06	3.51e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.32e-06	3.51e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—POMC—kidney cancer	2.32e-06	3.51e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.31e-06	3.49e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—kidney cancer	2.28e-06	3.45e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—kidney cancer	2.27e-06	3.44e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—kidney cancer	2.26e-06	3.41e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1B—kidney cancer	2.21e-06	3.34e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK1—kidney cancer	2.21e-06	3.34e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—BCHE—kidney cancer	2.21e-06	3.34e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—kidney cancer	2.2e-06	3.32e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.18e-06	3.3e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—kidney cancer	2.16e-06	3.27e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—kidney cancer	2.16e-06	3.27e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ABCB1—kidney cancer	2.15e-06	3.26e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—POMC—kidney cancer	2.12e-06	3.22e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—kidney cancer	2.11e-06	3.19e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.11e-06	3.19e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JUN—kidney cancer	2.1e-06	3.18e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTM1—kidney cancer	2.09e-06	3.16e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.09e-06	3.16e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—kidney cancer	2.09e-06	3.16e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—kidney cancer	2.09e-06	3.16e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—kidney cancer	2.03e-06	3.08e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.98e-06	3e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—kidney cancer	1.96e-06	2.96e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	1.92e-06	2.9e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—kidney cancer	1.91e-06	2.89e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.91e-06	2.88e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—POMC—kidney cancer	1.9e-06	2.87e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—kidney cancer	1.85e-06	2.8e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—POMC—kidney cancer	1.85e-06	2.8e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—kidney cancer	1.85e-06	2.8e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—kidney cancer	1.85e-06	2.79e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—kidney cancer	1.84e-06	2.78e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—kidney cancer	1.76e-06	2.66e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—POMC—kidney cancer	1.74e-06	2.64e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK3—kidney cancer	1.74e-06	2.63e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—POMC—kidney cancer	1.73e-06	2.62e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—kidney cancer	1.71e-06	2.58e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—kidney cancer	1.69e-06	2.56e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—kidney cancer	1.69e-06	2.56e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.67e-06	2.52e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—kidney cancer	1.66e-06	2.52e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCB1—kidney cancer	1.66e-06	2.52e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK1—kidney cancer	1.65e-06	2.5e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.63e-06	2.46e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTM1—kidney cancer	1.61e-06	2.44e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—kidney cancer	1.61e-06	2.44e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—kidney cancer	1.56e-06	2.36e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—kidney cancer	1.55e-06	2.35e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.53e-06	2.31e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.53e-06	2.31e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—kidney cancer	1.51e-06	2.29e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—kidney cancer	1.48e-06	2.24e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—POMC—kidney cancer	1.48e-06	2.24e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—kidney cancer	1.48e-06	2.23e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—kidney cancer	1.44e-06	2.17e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—kidney cancer	1.39e-06	2.11e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—kidney cancer	1.39e-06	2.1e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—kidney cancer	1.38e-06	2.09e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—kidney cancer	1.32e-06	2e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—kidney cancer	1.29e-06	1.95e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—kidney cancer	1.21e-06	1.84e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.2e-06	1.82e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—kidney cancer	1.2e-06	1.82e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—kidney cancer	1.18e-06	1.78e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—POMC—kidney cancer	1.14e-06	1.73e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.14e-06	1.72e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.04e-06	1.58e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—kidney cancer	1.03e-06	1.56e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—kidney cancer	9.31e-07	1.41e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—kidney cancer	9.1e-07	1.38e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—kidney cancer	9.08e-07	1.37e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.56e-07	1.3e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—kidney cancer	8.49e-07	1.28e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—kidney cancer	7.93e-07	1.2e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.25e-07	1.1e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.6e-07	8.47e-06	CbGpPWpGaD
